Showing results (511-520 of 915) with videos related to
Sort By:
Pageof 92
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 3, 2009
Methotrexate clearance by high-flux hemodialysis and peritoneal dialysis: a case reportMiho Murashima, Jill Adamski, Michael C Milone, et al.Molecular Phylogenetics and Evolution|December 20, 2011
It's a family matter: molecular phylogenetics of Atheriniformes and the polyphyly of the surf silversides (family: Notocheiridae)Devin D Bloom, Peter J Unmack, Atila E Gosztonyi, et al.Chest|March 20, 2010
Laser tissue welding in lung and tracheobronchial repair: an animal modelBenjamin S Bleier, Neri M Cohen, Jason D Bloom, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 10, 2015
Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxisD R Stevens, D Sawinski, E Blumberg, et al.Community Mental Health Journal|January 1, 1987
The prevalence and significance of medical illness among chronically mentally ill outpatientsR A Maricle, W F Hoffman, J D Bloom, et al.Journal of the American Geriatrics Society|September 14, 2010
How should we use age to ration health care? Lessons from the case of kidney transplantationPeter P Reese, Arthur L Caplan, Roy D Bloom, et al.Journal of Medicinal Chemistry|October 1, 1989
Potential antiatherosclerotic agents. 6. Hypocholesterolemic trisubstituted urea analoguesV G DeVries, J D Bloom, M D Dutia, et al.The Bulletin of the American Academy of Psychiatry and the Law|January 1, 1987
Treatment refusal among forensic inpatientsJ T Young, J D Bloom, L R Faulkner, et al.The Bulletin of the American Academy of Psychiatry and the Law|January 1, 1988
Drug treatment refusal and length of hospitalization of insanity acquitteesM H Williams, J D Bloom, L R Faulkner, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 31, 2008
Calcineurin inhibitor withdrawal after renal transplantation with alemtuzumab: clinical outcomes and effect on T-regulatory cellsJ Pascual, D Bloom, J Torrealba, et al.Pageof 92